logo
The emergence of high-resolution MS as the premier analytical tool in the pharmaceutical bioanalysis arena
HRMS: current usage, future directions and the promise of integration with unified data streams suited to post-acquisition mining
Two to tango: dual combination to enhance drug selectivity
Semi-targeted analysis of metabolites using capillary-flow ion chromatography coupled to HRMS
Proof-of-concept study suggests new method for quantitative pharmacology
Hatching: EBF conference announcement
Dako announce third collaborative project
Conference Report: High-resolution MS in drug discovery and development: current applications and future perspectives
Using high-resolution quadrupole TOF technology in DMPK analyses
Application of LC–high-resolution MS with ‘intelligent’ data mining tools for screening reactive drug metabolites
Integrated quantitative and qualitative workflow for in vivo bioanalytical support in drug discovery using hybrid Q-TOF-MS
Large molecule bioanalysis using Q-TOF without predigestion and its data processing challenges
Automated and unbiased analysis of LC–MS metabolomic data
Comparison of unit resolution SRM and TOF-MS at 12,000 mass resolution for quantitative bioanalysis of 11 steroids from human plasma
Comparison of triple quadrupole and high-resolution TOF-MS for quantification of peptides
Cassette incubation followed by bioanalysis using high-resolution MS for in vitro ADME screening assays
Identifying metabolite ions of peptide drugs in the presence of an in vivo matrix background
Comparison of the quantification of a therapeutic protein using nominal and accurate mass MS/MS
Acknowledgements